Roles of CD4+ T cells as mediators of antitumor immunity is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 84 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R35 CA197078
NCI NIH HHS
Grant: P30 CA014520
National Institutes of Health
Grant: 1R35CA197078-01
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
National Institutes of Health
Grant: 5P01CA250972-02
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
National Institutes of Health
Grant: 5P30CA014520-40
Clinical Research Coordinating Office
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Effects of reprogrammed splenic CD8+ T-cells in vitro and in mice with spontaneous metastatic Lewis lung carcinoma
Additional file 1 of Effects of reprogrammed splenic CD8+ T-cells in vitro and in mice with spontaneous metastatic Lewis lung carcinoma